Trial · NCT03226067
Results by group249
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 249
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Percent Change in Serum GGT. | GKT137831 400mg Once Daily | -4.9 | Standard Deviation 59.58 | percent change | |
| The Percent Change in Serum GGT. | GKT137831 400mg Twice Daily | -19 | Standard Deviation 28.89 | percent change | |
| The Percent Change in Serum GGT. | Placebo Arm | -8.4 | Standard Deviation 21.45 | percent change | |
| Absolute Change in Serum GGT | GKT137831 400mg Once Daily | Absolute change W2 | -14.3 | Standard Deviation 112.66 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Twice Daily | Absolute change W2 | -48.5 | Standard Deviation 61.83 | U/L |
| Absolute Change in Serum GGT | Placebo Arm | Absolute change W2 | -11.2 | Standard Deviation 45.96 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Once Daily | Absolute change W6 | -22.2 | Standard Deviation 76.68 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Twice Daily | Absolute change W6 | -53.5 | Standard Deviation 67.57 | U/L |
| Absolute Change in Serum GGT | Placebo Arm | Absolute change W6 | -17.9 | Standard Deviation 59.01 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Once Daily | Absolute change W12 | -3.9 | Standard Deviation 115.13 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Twice Daily | Absolute change W12 | -50.6 | Standard Deviation 74.7 | U/L |
| Absolute Change in Serum GGT | Placebo Arm | Absolute change W12 | -8.6 | Standard Deviation 70.11 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Once Daily | Absolute change W18 | -19.2 | Standard Deviation 134.32 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Twice Daily | Absolute change W18 | -37.9 | Standard Deviation 93.88 | U/L |
| Absolute Change in Serum GGT | Placebo Arm | Absolute change W18 | -4.5 | Standard Deviation 79.81 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Once Daily | Absolute change W24 | -17.9 | Standard Deviation 117.62 | U/L |
| Absolute Change in Serum GGT | GKT137831 400mg Twice Daily | Absolute change W24 | -43.6 | Standard Deviation 62.22 | U/L |
| Absolute Change in Serum GGT | Placebo Arm | Absolute change W24 | -10.7 | Standard Deviation 78.2 | U/L |
| Percent Change in Serum GGT | GKT137831 400mg Once Daily | Percent change W2 | -7 | Standard Deviation 25.08 | percent change |
| Percent Change in Serum GGT | GKT137831 400mg Twice Daily | Percent change W2 | -17 | Standard Deviation 17.25 | percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03226067/results